These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 17986163)
1. Complicated pain management in a CYP450 2D6 poor metabolizer. Foster A; Mobley E; Wang Z Pain Pract; 2007 Dec; 7(4):352-6. PubMed ID: 17986163 [TBL] [Abstract][Full Text] [Related]
2. Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer. Susce MT; Murray-Carmichael E; de Leon J Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1356-8. PubMed ID: 16631290 [TBL] [Abstract][Full Text] [Related]
3. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374 [TBL] [Abstract][Full Text] [Related]
4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers. de Leon J; Dinsmore L; Wedlund P J Clin Psychopharmacol; 2003 Aug; 23(4):420-1. PubMed ID: 12920424 [No Abstract] [Full Text] [Related]
6. CYP2D6 in the metabolism of opioids for mild to moderate pain. Leppert W Pharmacology; 2011; 87(5-6):274-85. PubMed ID: 21494059 [TBL] [Abstract][Full Text] [Related]
7. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy. Reynolds KK; Ramey-Hartung B; Jortani SA Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064 [TBL] [Abstract][Full Text] [Related]
8. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124 [TBL] [Abstract][Full Text] [Related]
9. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism. Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600 [TBL] [Abstract][Full Text] [Related]
10. Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype. Mikus G; Trausch B; Rodewald C; Hofmann U; Richter K; Gramatté T; Eichelbaum M Clin Pharmacol Ther; 1997 Apr; 61(4):459-66. PubMed ID: 9129563 [TBL] [Abstract][Full Text] [Related]
11. CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants. Haufroid V; Hantson P Clin Toxicol (Phila); 2015 Jul; 53(6):501-10. PubMed ID: 25998998 [TBL] [Abstract][Full Text] [Related]
12. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients. Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496 [TBL] [Abstract][Full Text] [Related]
13. Chronic Pain Management in a CYP2D6 Poor Metabolizer: A Case Report for Oxycodone. Pednekar D; Russell J; Bardolia C; Thacker D; Amin NS Sr Care Pharm; 2024 Apr; 39(4):137-142. PubMed ID: 38528335 [TBL] [Abstract][Full Text] [Related]
14. Observations on the urine metabolic profile of codeine in pain patients. Yee DA; Atayee RS; Best BM; Ma JD J Anal Toxicol; 2014 Mar; 38(2):86-91. PubMed ID: 24396053 [TBL] [Abstract][Full Text] [Related]
15. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis. O'Connor AB; Zwemer FL; Hays DP; Feng C Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Manchikanti L; Manchikanti KN; Pampati V; Cash KA Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308 [TBL] [Abstract][Full Text] [Related]